<DOC>
	<DOC>NCT00195507</DOC>
	<brief_summary>This study will provide a direct comparison of 'continuous therapy' and 'intermittent therapy' with withdrawal and retreatment upon return of psoriasis.</brief_summary>
	<brief_title>Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Stable, active plaque psoriasis Failure to respond to the following systemic therapies: Methotrexate, Cyclosporine, PUVA or Fumarate Evidence of skin conditions other than psoriasis that would interfere with evaluations of the effect of the study Systemic psoriasis therapy within 28 days prior</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Psoriasis</keyword>
</DOC>